---
figid: PMC8789654__fonc-11-763539-g005
figtitle: Anti-Hepatocellular Carcinoma Effect and Molecular Mechanism of the Estrogen
  Signaling Pathway
organisms:
- NA
pmcid: PMC8789654
filename: fonc-11-763539-g005.jpg
figlink: /pmc/articles/PMC8789654/figure/f5/
number: F5
caption: The role and mechanism of the estrogen signaling pathway in viral liver cancer.
  The estrogen signaling pathway can inhibit the progress of HBV-related HCC by regulating
  inflammatory mediators. The products of HBV can in turn counteract the estrogen
  signaling pathway and inhibit its protective effect.
papertitle: Anti-Hepatocellular Carcinoma Effect and Molecular Mechanism of the Estrogen
  Signaling Pathway.
reftext: Yusheng Guo, et al. Front Oncol. 2021;11:763539.
year: '2021'
doi: 10.3389/fonc.2021.763539
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: hepatocellular carcinoma (HCC) | estrogen signaling pathway | tumor therapy
  | molecular mechanism | estrogen receptor
automl_pathway: 0.8918441
figid_alias: PMC8789654__F5
figtype: Figure
organisms_ner:
- Danio rerio
- Homo sapiens
redirect_from: /figures/PMC8789654__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8789654__fonc-11-763539-g005.html
  '@type': Dataset
  description: The role and mechanism of the estrogen signaling pathway in viral liver
    cancer. The estrogen signaling pathway can inhibit the progress of HBV-related
    HCC by regulating inflammatory mediators. The products of HBV can in turn counteract
    the estrogen signaling pathway and inhibit its protective effect.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - hbae5
  - myd88
  - irak1
  - hdac1
  - esr1
  - dre-mir-22a
  - tgfb1a
  - il6
  - tnfb
  - MYD88
  - IRAK1
  - NFKB1
  - EPHB2
  - MAPK1
  - MAPK3
  - HDAC1
  - ESR1
  - ERAL1
  - IL18
  - TGFB1
  - IL6
  - TNF
---
